| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
728,351 |
356,960 |
$34.08M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
426,555 |
302,278 |
$20.13M |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
131,839 |
98,488 |
$17.88M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
218,554 |
158,888 |
$17.47M |
| T2023 |
Targeted case management; per month |
58,986 |
53,760 |
$17.24M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
51,867 |
38,586 |
$8.12M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
128,996 |
81,485 |
$7.64M |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
112,524 |
109,150 |
$6.98M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
481,731 |
278,855 |
$5.94M |
| H0047 |
Alcohol and/or other drug abuse services, not otherwise specified |
12,561 |
12,488 |
$5.45M |
| 90832 |
Psychotherapy, 30 minutes with patient |
153,448 |
115,202 |
$5.30M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
40,010 |
32,566 |
$3.60M |
| G2087 |
Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month |
4,639 |
4,596 |
$1.67M |
| 90791 |
Psychiatric diagnostic evaluation |
11,367 |
10,380 |
$833K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
18,204 |
12,951 |
$559K |
| 99215 |
Prolong outpt/office vis |
5,983 |
4,680 |
$553K |
| H0038 |
Self-help/peer services, per 15 minutes |
20,431 |
13,250 |
$308K |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,268 |
2,938 |
$226K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,456 |
1,194 |
$77K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
669 |
634 |
$58K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
435 |
426 |
$38K |
| 99205 |
Prolong outpt/office vis |
308 |
274 |
$33K |
| 90834 |
Psychotherapy, 45 minutes with patient |
649 |
590 |
$31K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
345 |
50 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
485 |
430 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
214 |
184 |
$3K |
| H0001 |
Alcohol and/or drug assessment |
43 |
43 |
$2K |
| 99201 |
|
56 |
44 |
$1K |
| 99406 |
|
13 |
12 |
$129.35 |